Cefetamet

Cefetamet

SCHEMBL7863727

CON=C(C(=O)NC1C(=O)N2C(C(=O)O)=C(C)CS[C@@H]12)c1csc(N)n1

nearest known ligand 0.79

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NR1I2 O75469 6/20 0.79
▸ HTR2C P28335 1/20 0.79
▸ MAPT P10636 3/20 0.76
▸ PPARG P37231 2/20 0.76
▸ SLC22A6 Q4U2R8 2/20 0.76
▸ SLC22A8 Q8TCC7 2/20 0.76
▸ SLC22A11 Q9NSA0 2/20 0.76
▸ ALB P02768 1/20 0.76
▸ PTGS1 P23219 1/20 0.74
▸ PGR P06401 3/20 0.72
▸ PTGS2 P35354 1/20 0.72
▸ TDP1 Q9NUW8 5/20 0.67
▸ APEX1 P27695 3/20 0.67
▸ ABCC4 O15439 3/20 0.67
▸ LMNA P02545 2/20 0.67
▸ L3MBTL1 Q9Y468 2/20 0.67
▸ CYP1A2 P05177 1/20 0.67
▸ PKM P14618 1/20 0.67
▸ HSD17B10 Q99714 1/20 0.67
▸ ALDH1A1 P00352 1/20 0.67

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cefetamet SCHEMBL6567051 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL27492189 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL10587826 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL8795245 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL11328620 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL10587831 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL151099 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL65620 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL9367206 1.00 NR1I2 (0.79) NR1I2HTR2CMAPTPPARGSLC22A6
Cefetamet SCHEMBL2586142 0.99 NR1I2 (0.78) NR1I2HTR2CMAPTPPARGSLC22A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0025698-B1 CONTROLLED RELEASE FORMULATIONS ELI LILLY AND COMPANY (US) 1984-06-13 — — EP claimed
EP-0025698-A2 Controlled release formulations ELI LILLY AND COMPANY (US) 1981-03-25 — — EP claimed
EP-0690864-B1 CRYSTALLINE CEFTIOFUR FREE ACID UPJOHN CO (US) 2001-06-13 — — EP disclosed
US-5869649-A Process for producing cephalosporin antibiotics RANBAXY LABORATORIES LTD. (IN) 1999-02-09 — — US disclosed
EP-0690864-A1 CRYSTALLINE CEFTIOFUR FREE ACID PHARMACIA & UPJOHN COMPANY (US) 1996-01-10 — — EP disclosed
WO-1994020505-A1 CRYSTALLINE CEFTIOFUR FREE ACID THE UPJOHN COMPANY (US) 1994-09-15 — — WO disclosed
US-4716158-A CEPHALOSPORINS SUITABLE FOR ORAL ADMINISTRATION SANKYO COMPANY LIMITED (JP) 1987-12-29 — — US disclosed
US-4680390-A CEPHALOSPORINS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 1987-07-14 — — US disclosed
EP-0049118-B1 CEPHALOSPORIN DERIVATIVES, THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM SANKYO COMPANY LIMITED (JP) 1986-04-23 — — EP disclosed
US-4486425-A ANTIBIOTICS SANKYO COMPANY LIMITED (JP) 1984-12-04 — — US disclosed
EP-0025698-B1 CONTROLLED RELEASE FORMULATIONS ELI LILLY AND COMPANY (US) 1984-06-13 — — EP disclosed
EP-0049118-A2 Cephalosporin derivatives, their preparation and compositions containing them SANKYO COMPANY LIMITED (JP) 1982-04-07 — — EP disclosed
EP-0025698-A2 Controlled release formulations ELI LILLY AND COMPANY (US) 1981-03-25 — — EP disclosed
Send feedback